Background illustration for clinical trials search

Leukemia Clinical Trials

Browse 1,316 Leukemia clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Strength Training Exercise in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (STEP-ALL)

for
Leukemia, Acute Leukemia, Acute Lymphoid Leukemia,
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 6+

Code: NCT07634653

Recruiting

A Study of CHM-029 in Participants With NPM1 Mutated, KMT2A or NUP98 Rearranged AML

for
AML (Acute Myeloid Leukemia)
Location: Grand Rapids MI
Sponsor: Charm Therapeutics

Sex: All

Age: 18+

Code: NCT07751991

Phase1, Recruiting

Tempus Open Link for Individual Voices in Innovative Analytics Registry: Platform Protocol for Multimodal Real-World Evidence in Cancer

for
Cancer, Solid Tumor Cancer, Pediatric Acute Myeloid Leukemia,
Location: Chicago IL
Sponsor: Tempus AI

Sex: All

Age: 0+

Code: NCT07756034

Recruiting

Registry for Adults With Plasma Cell Disorders (PCD's)

for
Multiple Myeloma, Amyloidosis, Cryoglobulinemia,
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT03717844

Recruiting

Safety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance Disease

for
Leukemia
Location: Bethesda MD, Beverly Hills CA
Sponsor: Cambridge Antibody Technology

Sex: All

Age: 18+

Code: NCT00457860

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

for
LGLL - Large Granular Lymphocytic Leukemia,
Location: Boston MA, New Haven CT, New York NY, Fairfax VA,
Sponsor: Dren Bio

Sex: All

Age: 18+

Code: NCT05475925

Phase1, Phase2, Recruiting

Safety Study of CAT-8015 Immunoxin in Patients With NHL With Advance Disease

for
Leukemia, Non-Hodgkin's Lymphoma, NHL
Location: Bethesda MD, Beverly Hills CA
Sponsor: Cambridge Antibody Technology

Sex: All

Age: 18+

Code: NCT00515892

Phase1, Recruiting

Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia

for
Leukemia
Location: Boston MA, Memphis TN, Houston TX, Seattle WA
Sponsor: Dutch Childhood Oncology Group

Sex: All

Age: 0 - 1

Code: NCT00550992

Recruiting

Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease

for
Leukemia, Hairy Cell Leukemia, HCL
Location: Bethesda MD
Sponsor: Cambridge Antibody Technology

Sex: All

Age: 18+

Code: NCT00462189

Phase1, Recruiting

Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

for
T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 0+

Code: NCT00501826

Phase2, Recruiting

Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma

for
Relapsed CLL, Refractory CLL, Refractory Lymphoma
Location: Cleveland OH
Sponsor: Paolo Caimi, MD

Sex: All

Age: 18+

Code: NCT06916767

Phase1, Recruiting

Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation

for
Chronic Myeloproliferative Disorders, Kidney Cancer, Leukemia,
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin

Sex: All

Age: 2 - 18

Code: NCT00036712

Phase2, Recruiting

DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics

for
Hematologic Malignancies, Lymphoma, Multiple Myeloma, Leukemia,
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 60+

Code: NCT06296368

Recruiting

Polatuzumab Vedotin in Combination With Chemotherapy in Subjects With Richter's Transformation

for
Richter Syndrome, Chronic Lymphocytic Leukemia
Location: New York NY, Columbus OH
Sponsor: Weill Medical College of Cornell University

Sex: All

Age: 18+

Code: NCT04679012

Phase2, Recruiting

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

for
Acute Myeloid Leukemia, Myelodysplastic Syndromes,
Location: New York NY, Hackensack NJ, Tampa FL, Houston TX,
Sponsor: Orca Biosystems, Inc.

Sex: All

Age: 12 - 70+

Code: NCT03802695

Phase1, Recruiting

Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)

for
B-Cell Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 18+

Code: NCT06144606

Phase2, Recruiting
New

Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome

for
Acute Myeloid Leukemia With Complex Karyotype,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT07582172

Phase2, Recruiting
Featured

A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

for
Chronic Lymphocytic Leukemia
Location: Providence RI, Worcester MA, New Haven CT, New York NY,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06428019

Phase3, Recruiting
Featured

Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)

for
Chronic Lymphocytic Leukemia (CLL)
Location: Boston MA, Hackensack NJ, Philadelphia PA,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT04895436

Phase2, Recruiting

Assessment of Remote Approaches for Identification of Autonomic Dysfunction Among Survivors of Leukemia and Lymphoma

for
Childhood Cancer
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 18+

Code: NCT06747910

Recruiting

What are clinical trials for leukemia?

Clinical trials for leukemia are research studies designed to evaluate new treatments, therapies, or diagnostic methods for different types of leukemia, a group of cancers that affect the blood and bone marrow. These trials aim to discover more effective ways to treat leukemia, manage its symptoms, and improve patient outcomes. They may involve testing new drugs, combinations of existing treatments, targeted therapies, immunotherapies, or novel approaches like gene therapy.

Why are leukemia clinical trials important?

Leukemia clinical trials are crucial because they drive advancements in treatment by testing new therapies, improving existing ones, and exploring novel approaches to manage and potentially cure the disease. These trials provide essential data on the safety and effectiveness of new treatments, which can lead to better outcomes and fewer side effects compared to current options.

Types of clinical trials for leukemia

Why participate in a leukemia clinical trial

Who can participate in a clinical trial for leukemia?

How to enroll in a leukemia clinical trial